tiprankstipranks
Trending News
More News >

Wellgistics Health Achieves SOC 2 Type 1 Compliance

Story Highlights
  • Wellgistics Health partners with Draper for investor relations and business development.
  • Wellgistics Health achieves SOC 2 Type 1 compliance, boosting its security and industry trust.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Wellgistics Health Achieves SOC 2 Type 1 Compliance

Don’t Miss TipRanks’ Half-Year Sale

Wellgistics Health Inc ( (WGRX) ) has shared an update.

On March 17, 2025, Wellgistics Health, Inc. entered into a consulting agreement with Draper, Inc. to enhance its investor relations and business development. The agreement involves Draper providing financial analysis, industry reports, and assistance with potential mergers. In return, Draper receives restricted shares of Wellgistics Health’s common stock. Additionally, on March 18, 2025, Wellgistics Health announced its achievement of SOC 2 Type 1 compliance, validating its high standards for security and data protection. This compliance strengthens its position as a reliable provider of secure pharmacy solutions, enhancing trust with healthcare partners.

More about Wellgistics Health Inc

Wellgistics Health, Inc. is a holding company focused on healthcare technology and pharmaceutical services, aiming to create a micro health ecosystem. It offers a technology platform, pharmacy, and wholesale operations providing prescription hub and clinical services, with a focus on patient-centric care and integrated solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

YTD Price Performance: 4.46%

Average Trading Volume: 103,194

Find detailed analytics on WGRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1